Clik here to view.
实验室研究证实BETADINE®洁齿漱口水可有效杀灭COVID-19病毒
马来西亚吉隆坡 (美国商业资讯)–马来亚大学热带传染病教研中心(TIDREC)完成的实验室检测证实，BETADINE®洁齿漱口水可有效杀灭导致COVID-19疾病的新型冠状病毒(SARS-CoV-2)。BETADINE®在马来西亚由Mundipharma生产和销售。 按确立的欧洲(EN14476)方法和标准，检测两种浓度的BETADINE®洁齿漱口水的杀病毒活性：未稀释(PVP-I 1%...
View ArticleClik here to view.
Daiichi Sankyo Expands DS-1062 Study to Include Patients with Triple Negative...
TOKYO, MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient with triple negative breast cancer (TNBC) has been dosed in the...
View ArticleClik here to view.
COVID-19ウイルスに対するBETADINE®うがい・洗口液の有効性を裏付けるラボ研究
マレーシア・クアラルンプール （ビジネスワイヤ） — マレーシアのマラヤ大学熱帯感染症研究教育センター（TIDREC）が完了したラボ試験で、COVID-19疾患を引き起こす新型コロナウイルス（SARS-CoV-2）に対し、BETADINE®（ベタジン）うがい・洗口液が有効であることが裏付けられました。BETADINE®はマレーシアでムンディファーマが製造販売しています。...
View ArticleClik here to view.
HitGen and Morphic Extend Drug Discovery Research Collaboration
CHENGDU, China HitGen Inc. (HitGen, 688222.SH) announced today that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against...
View ArticleClik here to view.
EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan...
TOKYO & MUNICH Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA)...
View ArticleClik here to view.
Samyang Biopharm USA Announces Establishment of “Samyang CRS Award in Honor...
CAMBRIDGE, Mass. & SEOUL, South Korea Samyang Biopharm USA, Inc. (https://us.Samyangbiopharm.com) a global biotech subsidiary of the Samyang Pharmaceuticals Corp....
View ArticleClik here to view.
SCIEX Honors 50 Years of Innovation With Virtual Product Experience Launch
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, honors its 50th anniversary with the digital launch of pioneering products. On July 10th, the first of its kind...
View ArticleClik here to view.
Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical Announce FDA...
PLEASANTON, Calif. & PRINCETON, N.J. & TOKYO Astex Pharmaceuticals, Inc.; Taiho Oncology, Inc.; and Otsuka Pharmaceutical Co., Ltd. today announce that the U.S. Food and Drug Administration...
View ArticleClik here to view.
With Second Mevion Proton System Installed at Siteman Cancer Center,...
LITTLETON, Mass. Mevion Medical Systems announced today that patient treatment has commenced on the MEVION S250i Proton Therapy System® at the S. Lee Kling Proton Therapy Center at Siteman Cancer...
View ArticleClik here to view.
Takeda and the New York Academy of Sciences Announce 2020 Innovators in...
NEW YORK & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in...
View ArticleClik here to view.
RefleXion and Telix Pharmaceuticals Announce Strategic Collaboration for...
HAYWARD, Calif. & MELBOURNE, Australia RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, and...
View ArticleClik here to view.
武田和纽约科学院公布2020年科学创新者奖获得者
纽约和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）和纽约科学院(New York Academy of Sciences)今天公布了第三届年度科学创新者奖(Innovators in Science...
View ArticleClik here to view.
Harbour BioMed Raises $102.8M in Series C Financing to Accelerate Development...
Cambridge, MA, Rotterdam, NL, Suzhou CN Harbour BioMed (HBM) today announced completion of its Series C financing of $102.8 Million to accelerate development of its growing portfolio of next...
View ArticleClik here to view.
AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View ArticleClik here to view.
DRADS Capital Leads Series C Round for ROKIT Healthcare, a South Korean 4D...
SEOUL, South Korea DRADS Capital announced today its investment in ROKIT Healthcare Inc., a South Korean biotechnology company developing innovative 4D bioprinting techniques and applications, in...
View ArticleClik here to view.
JS InnoPharm Announces First Patient Dosed with JSI-1187, a Selective ERK...
CHICAGO & SHANGHAI JS InnoPharm Ltd today announced the enrollment of the first patient in a Phase 1, open-label, monotherapy dose-escalation and expansion study of JSI-1187, the company’s lead...
View ArticleClik here to view.
Fully Integrated SCIEX OS Software Launches at Virtual Product Experience
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, introduces the fully integrated SCIEX OS Software, the core engine running SCIEX innovations. Today, SCIEX OS...
View ArticleClik here to view.
The SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready Launches at...
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, launches the next generation of its flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System...
View ArticleClik here to view.
武田薬品とニューヨーク科学アカデミーが2020年Innovators in Science Awardの受賞者を発表
ニューヨーク & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（以下、「武田薬品」）（TSE:4502/NYSE:TAK）とニューヨーク科学アカデミーは本日、今年で第3回年次Innovators in Science...
View ArticleClik here to view.
BARDA to Initiate Procurement of the RECELL® System for Emergency Response...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View Article